Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 11040
Country/Region: Ethiopia
Year: 2016
Main Partner: United Nations High Commissioner for Refugees
Main Partner Program: NA
Organizational Type: Multi-lateral Agency
Funding Agency: enumerations.State/PRM
Total Funding: $2,000,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $208,911
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $44,457
Care: Pediatric Care and Support (PDCS) $4,344
Strategic Information (HVSI) $50,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $122,400
Biomedical Prevention: Injection Safety (HMIN) $0
Testing: HIV Testing and Counseling (HVCT) $309,750
Sexual Prevention: Other Sexual Prevention (HVOP) $605,114
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $197,115
Treatment: Adult Treatment (HTXS) $439,846
Treatment: Pediatric Treatment (PDTX) $18,063
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 30
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 30
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 30
GEND_GBV Number of people receiving post-GBV care 2017 60
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 791
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 791
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 27,230
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 6,890
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 36,334
HTS_TST Service Delivery Point (Facility): Inpatient 2017 6,700
HTS_TST Service Delivery Point (Facility): Outpatient 2017 6,700
HTS_TST Service Delivery Point (Facility): PMTCT 2017 250
HTS_TST Service Delivery Point (Facility): VCT 2017 17,024
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,582
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 34,120
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 35,702
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 49
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 41
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 678
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 206
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 310
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 315
KP_PREV Total estimated number of key population in the catchment area 2017 593
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 583
PMTCT_ART Already on ART at beginning of current pregnancy 2017 85
PMTCT_ART New on ART 2017 118
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 16,211
PMTCT_STAT By: Known positives at entry 2017 71
PMTCT_STAT By: Number of new positives identified 2017 99
PMTCT_STAT Number of new ANC and L&D clients 2017 17,502
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 16,211
PMTCT_STAT Sum of Positives Status disaggregates 2017 170
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 11,000
PP_PREV Total number of people in the target population 2017 554,286
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 43
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 35
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 6
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 6
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,562
TX_CURR Aggregated Age/Sex: <15 Female 2017 66
TX_CURR Aggregated Age/Sex: <15 Male 2017 66
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,121
TX_CURR Aggregated Age/Sex: 15+ Male 2017 346
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,066
TX_CURR Sum of Aggregated Age/Sex <15 2017 132
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,467
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,599
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 18
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 104
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 51
TX_NEW By Age/Sex: 20-24 Female 2017 1
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 282
TX_NEW Sum of Age/Sex disaggregates 2017 1
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 196
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 20
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 337
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 377
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
VMMC_CIRC By Age: 10-14 2017 40
VMMC_CIRC By Age: 15-19 2017 260
VMMC_CIRC By Age: 20-24 2017 330
VMMC_CIRC By Age: 25-29 2017 120
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 640
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 700
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 750
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 630